Picture of Phaxiam Therapeutics SA logo

PHXM — Phaxiam Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes

June 5 (Reuters) - Erytech Pharma  ERYP.PA :
    * ERYTECH ANNOUNCES THAT AKKADIAN HAS INITIATED PROCEEDINGS
TO
POSTPONE THE VOTE ON THE MERGER WITH PHERECYDES
    * AKKADIAN IS ALSO REQUESTING APPOINTMENT OF A LEGAL EXPERT
TO
REVIEW TERMS OF MERGER
    * INTENDS TO OBTAIN DISMISSAL OF THIS LEGAL ACTION, WHICH IT
CONSIDERS UNFOUNDED, AND THUS ENABLE ITS SHAREHOLDERS TO VOTE ON
MERGER WITH PHERECYDES ON JUNE 23

Source text for Eikon:  ID:nGNE7TzfKY 
Further company coverage:  ALPHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Phaxiam Therapeutics SA

See all news